Electric Wheelchair Market CAGR of 6.8%: Top 10 Companies Leading According to a newly published market research report by 24LifeSciences, global electric wheelchair market was valued at USD 3.7 billion in 2024 and is projected to reach USD 6.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2025–2032. An electric wheelchair, also known as a powerchair or electric-powered wheelchair (EPW), is a motorized mobility device essential for individuals with limited strength, endurance, or dexterity. These devices provide critical independence for users with conditions including spinal cord injuries, muscular dystrophy, multiple sclerosis, advanced arthritis, and age-related mobility decline. Unlike manual wheelchairs, EPWs utilize electric motors and rechargeable battery systems, enabling users to navigate both indoor and outdoor environments with greater autonomy and reduced physical strain. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11020/electric-wheelchair-market

Global Pressure Infusor Market to Hit USD 280 Million by 2032 According to a newly published market research report by 24LifeSciences, global pressure infusor market was valued at USD 224 million in 2024 and is projected to reach USD 280 million by 2031, growing at a compound annual growth rate (CAGR) of 3.4% during the forecast period 2025–2031. A pressure infusor is a vital medical device, essentially a cuff and bladder system, specifically designed to pressurize sterile parenteral fluids such as blood or intravenous (IV) solutions. This controlled pressurization enables the rapid infusion of these critical fluids into a patient's bloodstream, which is a paramount intervention for managing hypovolemiaa life-threatening condition characterized by a dangerously low volume of circulating bloodand its severe complications. These devices are indispensable in high-acuity clinical environments, including emergency rooms, operating theaters, and intensive care units, where time-sensitive volume resuscitation can be the difference between life and death. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7253/pressure-infusor-market

Disposable Hydrocephalus Shunt Market Forecast: Opportunities to 2032 According to a newly published market research report by 24LifeSciences, global disposable hydrocephalus shunt market was valued at USD 437 million in 2023 and is projected to reach USD 723 million by 2030, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2024–2030. Disposable hydrocephalus shunts are single-use medical devices designed to divert excess cerebrospinal fluid (CSF) from the brain to other body cavities, primarily the abdominal cavity or heart chambers. Unlike reusable shunts, these disposable variants significantly reduce the risk of healthcare-associated infections and cross-contamination, making them particularly valuable in infection-sensitive environments. Their simplified design also streamlines surgical procedures, reduces operative time, and offers superior clinical adaptability for managing intracranial pressure. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3875/disposable-hydrocephalus-shunt--global-outlook-and-market

Ibuprofen API Market Outlook 2025: Supply Chain & Pricing Trends According to a newly published market research report by 24LifeSciences, global ibuprofen market was valued at USD 3.87 billion in 2024 and is projected to reach USD 4.98 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period 2025–2031. Ibuprofen, a leading nonsteroidal anti-inflammatory drug (NSAID), is globally recognized for its potent analgesic, antipyretic, and anti-inflammatory properties. As an Active Pharmaceutical Ingredient (API), it serves as the foundational component in numerous over-the-counter and prescription medications designed to treat common conditions such as headaches, muscle pain, arthritis, dental pain, and fever. Its established efficacy and favorable safety profile at recommended doses continue to make it a cornerstone of global pain management strategies. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/669buprofen-market-market

Top 10 Key Players Transforming the Classical Swine Fever Vaccines Market According to a newly published market research report by 24LifeSciences, global classical swine fever vaccines market was valued at USD 153 million in 2024 and is projected to reach USD 214 million by 2032, growing at a compound annual growth rate (CAGR) of 5.0% during the forecast period 2025–2032. Classical swine fever vaccines are biological preparations used to protect pigs against the highly contagious classical swine fever virus (CSFV), which belongs to the Pestivirus genus. These vaccines play a critical role in preventing disease outbreaks that can decimate swine populations and disrupt pork supply chains globally. The vaccine types primarily include live attenuated vaccines, inactivated vaccines, and newer subunit vaccines, with tissue culture origin vaccines currently dominating the market with approximately 66% share. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1606/classical-swine-fever-vaccines-market

Enteral Medicine Straw Market Size to Reach USD 5.8 Million by 2034 | Trends & Forecasts According to a newly published market research report by 24LifeSciences, global enteral medicine straw market was valued at USD 4.2 million in 2024 and is projected to reach USD 5.8 million by 2032, growing at a compound annual growth rate (CAGR) of 4.1% during the forecast period 2025–2032. Enteral medicine straws are specialized medical devices designed for the safe and accurate oral administration of liquid or powdered medication to patients with dysphagia or those reliant on enteral feeding tubes. These single-use, calibrated straws are critical for ensuring precise dosing, preventing tube occlusions, and minimizing contamination risks in both clinical and homecare settings. Their role in facilitating effective medication delivery for vulnerable patient populations underpins their essential position in supportive care management. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10708/enteral-medise-straw-market

Global Natural Bioidentical DHEA Cream Market Size & Forecast to 2032 According to a newly published market research report by 24LifeSciences, global Natural Bioidentical DHEA Cream market was valued at USD 2.1 million in 2024 and is projected to reach USD 2.9 million by 2031, growing at a compound annual growth rate (CAGR) of 4.6% during the forecast period 2024–2031. Natural bioidentical DHEA cream contains dehydroepiandrosterone (DHEA) derived from plant-based sources such as wild yam or soy, which are structurally identical to endogenous human DHEA. This characteristic enables its application in anti-aging regimens, hormonal balance therapies, and sexual wellness enhancement without the molecular risks associated with synthetic hormone replacement. These topical formulations offer a targeted approach to addressing hormonal decline, primarily serving consumers seeking natural alternatives to conventional medical treatments. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4072/natural-bioidentical-dhea-cream-market

How Clean Label Trends Drive Wellness F&B Market Growth According to a newly published market research report by 24LifeSciences, Global Health and Wellness Food and Drinks Market was valued at USD 116,600 million in 2024 and is projected to reach USD 181,810 million by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2024-2031. The health and wellness food and drinks market encompasses products specifically formulated to deliver health benefits that extend beyond basic nutrition. This sector includes a diverse range of offerings, from dietary supplements and functional beverages to fortified foods and organic products, all designed to support proactive health management, prevent disease, and enhance overall well-being. The market's robust expansion is primarily fueled by a global surge in health consciousness, rising disposable incomes, and a significant shift towards preventive healthcare strategies among consumers worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4127/health-and-wellness-food-and-drinks-market

Oligonucleotide CDMO Market’s CAGR of 8.9%: Key Players According to a newly published market research report by 24LifeSciences, global oligonucleotide process development and manufacturing market was valued at USD 1.14 billion in 2024 and is projected to reach USD 2.04 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025-2031. Oligonucleotides, which are short, single-stranded DNA or RNA molecules typically consisting of 20 to 30 nucleotides, play crucial roles in antisense therapy, gene silencing, and as primers or probes in molecular biology. The manufacturing process involves sophisticated techniques including solid-phase synthesis using phosphoramidite chemistry, followed by deprotection, cleavage, purification (typically using reverse-phase HPLC), and rigorous quality control analysis to ensure high purity and correct sequence integrity. These precision molecules continue to underpin the advancement of nucleic acid therapeutics and personalized medicine approaches. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5182/oligonucleotide-process-development-and-manufacturing-market

Top 7 Innovations in HA-Based Nutraceuticals According to a newly published market research report by 24LifeSciences, global health food hyaluronic acid market was valued at USD 1.15 billion in 2024 and is projected to reach USD 2.45 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.8% during the forecast period 2025-2032. Health Food Hyaluronic Acid, a high-purity glycosaminoglycan, is increasingly incorporated into nutraceuticals and dietary supplements for its dual benefits in enhancing skin hydration and supporting joint health. Unlike topical applications, these ingestible products are designed to deliver systemic benefits from within, primarily by improving synovial fluid viscosity which helps relieve osteoarthritis symptoms. Its growing prominence is underpinned by extensive clinical research validating its efficacy and safety for oral consumption. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/12388/health-food-hyaluronic-acid-market